Product #: GP100060

IFNα2b(102-108)-Tn(105)

Sequence:

Synthetic glycopeptide fragment of Interferon alpha 2b, IFNα2b, marketed for therapeutic use as Intron-A®. The peptide sequence VGVTETP corresponds to positions 103-109 of the mature IFNα2b protein with α-GalNAc glycosylation (Tn Antigen) ocurring at Thr105. The C-terminus is an amide.

VGVT*ETP-NH2
H-Val-Gly-Val-Thr*-Glu-Thr-Pro-NH2
where T* = Thr* = GalNAcα-O-Thr

IFNα2b(102-108)-Tn(105)

Synthetic glycopeptide fragment of Interferon alpha 2b, IFNα2b, marketed for therapeutic use as Intron-A®. The peptide sequence VGVTETP corresponds to positions 103-109 of the mature IFNα2b protein with α-GalNAc glycosylation (Tn Antigen) ocurring at Thr105. The C-terminus is an amide.

Sequence:

VGVT*ETP-NH2
H-Val-Gly-Val-Thr*-Glu-Thr-Pro-NH2
where T* = Thr* = GalNAcα-O-Thr

    1 0

    In Stock
    Inquire for pricing View full details

      Product Details

      • Technical Data

        UniProt ID: Q6QNB6

        Formula: C44H71N9O19

        Molecular Weight: 903.97

        Purity: >90% (HPLC)

      • Storage & Shipping

        Shipping requirement: Dry Ice

        Storage conditions: -20°C

      • Documentation

        Email: info@sussex-research.com

      1 3